157 related articles for article (PubMed ID: 8788497)
1. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
[TBL] [Abstract][Full Text] [Related]
2. [3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.
Dean B; Opeskin K; Pavey G; Naylor L; Hill C; Keks N; Copolov DL
J Neurochem; 1995 Mar; 64(3):1197-202. PubMed ID: 7861151
[TBL] [Abstract][Full Text] [Related]
3. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
Naylor L; Dean B; Opeskin K; Pavey G; Hill C; Keks N; Copolov D
J Neural Transm (Vienna); 1996; 103(6):749-57. PubMed ID: 8836936
[TBL] [Abstract][Full Text] [Related]
4. No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.
Dean B; Tomaskovic-Crook E; Opeskin K; Keks N; Copolov D
Neurochem Int; 1999 Feb; 34(2):109-15. PubMed ID: 10213068
[TBL] [Abstract][Full Text] [Related]
5. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
[TBL] [Abstract][Full Text] [Related]
6. The serotonin transporter from human brain: purification and partial characterization.
Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.
Abe S; Hori T; Suzuki T; Baba A; Shiraishi H; Yamamoto T
Neurochem Res; 1999 Mar; 24(3):359-63. PubMed ID: 10215509
[TBL] [Abstract][Full Text] [Related]
8. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
Dean B; Hussain T; Hayes W; Scarr E; Kitsoulis S; Hill C; Opeskin K; Copolov DL
J Neurochem; 1999 Apr; 72(4):1593-9. PubMed ID: 10098866
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
Gurevich EV; Joyce JN
Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
[TBL] [Abstract][Full Text] [Related]
11. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
Duncan MJ; Hensler JG
Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
[TBL] [Abstract][Full Text] [Related]
12. A proposed pathological model in the hippocampus of subjects with schizophrenia.
Scarr E; Copolov DL; Dean B
Clin Exp Pharmacol Physiol; 2001; 28(1-2):70-3. PubMed ID: 11153541
[TBL] [Abstract][Full Text] [Related]
13. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.
Yau JL; Kelly PA; Olsson T; Noble J; Seckl JR
Neurosci Lett; 1999 Feb; 261(3):183-5. PubMed ID: 10081979
[TBL] [Abstract][Full Text] [Related]
14. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
[TBL] [Abstract][Full Text] [Related]
15. Presence and characterization of the serotonin transporter in human resting lymphocytes.
Marazziti D; Rossi A; Giannaccini G; Baroni S; Lucacchini A; Cassano GB
Neuropsychopharmacology; 1998 Aug; 19(2):154-9. PubMed ID: 9629569
[TBL] [Abstract][Full Text] [Related]
16. The effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain.
Kulikov AV; Jeanningro R
Neurosci Behav Physiol; 2001; 31(4):445-9. PubMed ID: 11508497
[TBL] [Abstract][Full Text] [Related]
17. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
18. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
Pinto W; Battaglia G
Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
[TBL] [Abstract][Full Text] [Related]
19. Platelet serotonergic binding sites in alcohol-dependent patients.
Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
